Results 1 to 10 of about 1,220,992 (120)
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee [PDF]
Osong Public Health and Research Perspectives, 2023 With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events.Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi +10 moredoaj +1 more sourceCaracterísticas clínicas y evolución de la infección por SARS-CoV-2 en pacientes con lupus eritematoso sistémico en Argentina: datos del registro nacional SAR-COVID
Revista Argentina de Reumatología, 2022
Introducción: el lupus eritematoso sistémico (LES) es una enfermedad sistémica que se ha asociado a mayor severidad con la infección por SARS-CoV-2. Particularmente la alta actividad de la enfermedad y algunos inmunosupresores se han vinculado a peores ...Carolina Ayelén Isnardi, Karen Roberts, Yohana Tissera, Ingrid Petkovic, Guillermo Berbotto, Carla Gobbi, Romina Tanten, Karina Cogo, Cecilia Asnal, Andrea Baños, Florencia Vivero, María Marcela Schmid, María Alicia Lázaro, Noelia German, Lorena Takashima, Julia Scafati, Marina Laura Werner, Luciana Casalla, Carla Matellan, Diana M. Castrillon, Florencia Rodríguez, Sebastián Moyano, María Luz Martín, Vanesa Cosentino, Natalia Herscovich, Elda R. Tralice, Tatiana Barbich, Dora L. Vásquez, Emilio Buschiazzo, Pablo Maid, Ana C. Ledesma, Víctor Yohena, Gimena Gómez, Rosana Quintana, Guillermo J. Pons-Estel +34 moredoaj +1 more sourceModel-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Communications Medicine, 2021 Coutinho et al. use genomic and epidemiological data from Manaus, Brazil, to estimate the transmissibility and potential for reinfection with the SARS-CoV-2 variant-of-concern P.1 (gamma).Renato Mendes Coutinho, Flavia Maria Darcie Marquitti, Leonardo Souto Ferreira, Marcelo Eduardo Borges, Rafael Lopes Paixão da Silva, Otavio Canton, Tatiana P. Portella, Silas Poloni, Caroline Franco, Mateusz M. Plucinski, Fernanda C. Lessa, Antônio Augusto Moura da Silva, Roberto Andre Kraenkel, Maria Amélia de Sousa Mascena Veras, Paulo Inácio Prado +14 moredoaj +1 more sourceThe World Health Organization COVID-19 surveillance database
International Journal for Equity in Health, 2022 In January 2020, SARS-CoV-2 virus was identified as a cause of an outbreak in China. The disease quickly spread worldwide, and the World Health Organization (WHO) declared the pandemic in March 2020. From the first notifications of spread of the disease, Maya Allan, Maja Lièvre, Henry Laurenson-Schafer, Stéphane de Barros, Yuka Jinnai, Sophie Andrews, Thomas Stricker, Jesus Perez Formigo, Craig Schultz, Anne Perrocheau, Julia Fitzner +10 moredoaj +1 more sourceAssessment of Anti-SARS-CoV-2 antibody levels among university students vaccinated with different COVID-19 primary and booster doses — fall 2021, Wisconsin
BMC Infectious Diseases, 2023 Background University students commonly received COVID-19 vaccinations before returning to U.S. campuses in the Fall of 2021. Given likely immunologic variation among students based on differences in type of primary series and/or booster dose vaccine ...Peter M. DeJonge, Anastasia S. Lambrou, Hannah E. Segaloff, Allen Bateman, Alana Sterkel, Carol Griggs, Jake Baggott, Patrick Kelly, Natalie Thornburg, Monica Epperson, Rodel Desamu-Thorpe, Glen Abedi, Christopher H. Hsu, Jasmine Y. Nakayama, Jasmine Ruffin, Darlene Turner-Harper, Almea Matanock, Olivia Almendares, Melissa Whaley, Ayan Chakrabarti, Kyle DeGruy, Michele Daly, Ryan Westergaard, Jacqueline E. Tate, Hannah L. Kirking +24 moredoaj +1 more sourceA cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
BMC Infectious Diseases, 2022 Background To improve understanding of the antibody response to SARS-CoV-2 infection, we examined seroprevalence, incidence of infection, and seroconversion among a cohort of young adults living on university campuses during the fall of 2020.Christine C. Lee, Hannah E. Segaloff, Devlin Cole, Hannah G. Rosenblum, Clint N. Morgan, Tarah Somers, Rodel Desamu-Thorpe, Monique A. Foster, Dustin Currie, Jeanne Ruff, David Payne, Thomas J. Whyte, Glen R. Abedi, John Paul Bigouette, Juliana Kahrs, Kimberly Langolf, Patrick Remington, Alana Sterkel, Patrick Kelly, Ryan P. Westergaard, Allen C. Bateman, Christopher H. Hsu, Jacqueline E. Tate, Hannah L. Kirking +23 moredoaj +1 more sourceCountries with delayed COVID-19 introduction – characteristics, drivers, gaps, and opportunities
Globalization and Health, 2021 Background Three months after the first reported cases, COVID-19 had spread to nearly 90% of World Health Organization (WHO) member states and only 24 countries had not reported cases as of 30 March 2020. This analysis aimed to 1) assess characteristics, Zheng Li, Cynthia Jones, Girum S. Ejigu, Nisha George, Amanda L. Geller, Gregory C. Chang, Alys Adamski, Ledor S. Igboh, Rebecca D. Merrill, Philip Ricks, Sara A. Mirza, Michael Lynch +11 moredoaj +1 more sourceNeurocognitive Disorders in Post and Long Covid Patients: Preliminary Data, Gender Differences and New Diabetes Diagnosis
Diabetology, 2022 The research is based on a clinical observation of the neurological and neuro-cognitive status of 300 patients, belonging to the Partinico Hospital and the Post-Long Covid clinic, which had contracted the SARS-CoV-2 virus in the period between April 2021 Concetta Mezzatesta, Sara Bazzano, Rosa Gesualdo, Simone Marchese, Maria Luisa Savona, Mario Tambone Reyes, Vincenzo Provenzano +6 moredoaj +1 more sourceHarnessing peak transmission around symptom onset for non-pharmaceutical intervention and containment of the COVID-19 pandemic
Nature Communications, 2021 Transmission by pre-symptomatic and asymptomatic viral carriers makes intervention and containment of the COVID-19 extremely challenging. Here, the authors construct an epidemiological model that focuses on transmission around the symptom onset ...Liang Tian, Xuefei Li, Fei Qi, Qian-Yuan Tang, Viola Tang, Jiang Liu, Zhiyuan Li, Xingye Cheng, Xuanxuan Li, Yingchen Shi, Haiguang Liu, Lei-Han Tang +11 moredoaj +1 more sourcePleomorphicskin eruptions in a COVID‐19 affected patient: Case report and review of the literature
Immunity, Inflammation and Disease, 2021 The coronavirus disease (COVID‐19), during its course, may involve several organs, including the skin with a petechial skin rash, urticaria and erythematous rash, or varicella‐like eruption, representing an additional effect of the severe acute ...Enrico Scala, Luca Fania, Filippo Bernardini, Rodolfo Calarco, Sabrina Chiloiro, Cristiana Di Campli, Sabrina Erculei, Mauro Giani, Marzia Giordano, Annarita Panebianco, Francesca Passarelli, Andrea Trovè, Sofia Verkhovskaia, Giandomenico Russo, Antonio Sgadari, Biagio Didona, Damiano Abeni +16 moredoaj +1 more source